133 related articles for article (PubMed ID: 7727857)
21. Limited role of cell kinetics in clinical cancer chemotherapy.
Hall TC
Natl Cancer Inst Monogr; 1971 Dec; 34():15-7. PubMed ID: 4946579
[No Abstract] [Full Text] [Related]
22. Adjunctive agents in systemic chemotherapy.
Lyman GH
Compr Ther; 1980 Oct; 6(10):16-25. PubMed ID: 6778649
[No Abstract] [Full Text] [Related]
23. Clinical problems of resistance to cancer chemotherapeutic agents.
Lane M
Fed Proc; 1979 Jan; 38(1):103-7. PubMed ID: 759229
[No Abstract] [Full Text] [Related]
24. Drug resistance in cancer - searching for mechanisms, markers and therapeutic agents.
O'Connor R; Clynes M; Dowling P; O'Donovan N; O'Driscoll L
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):805-17. PubMed ID: 18028026
[TBL] [Abstract][Full Text] [Related]
25. Modern chemotherapy in solid tumours.
Kaye SB
Q J Med; 1994 Jun; 87(6):319-22. PubMed ID: 8041863
[No Abstract] [Full Text] [Related]
26. First Annual Pezcoller Symposium. Drug resistance--mechanisms and reversal.
Mihich E
Cancer Res; 1989 Dec; 49(24 Pt 1):7168-71. PubMed ID: 2582457
[No Abstract] [Full Text] [Related]
27. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy.
Shah MA; Schwartz GK
Clin Cancer Res; 2001 Aug; 7(8):2168-81. PubMed ID: 11489790
[TBL] [Abstract][Full Text] [Related]
28. [Aimed chemotherapy of malignancies].
Andrysek O
Cas Lek Cesk; 1974 Jul; 113(28):850-3. PubMed ID: 4848005
[No Abstract] [Full Text] [Related]
29. New test reveals extreme drug resistance in many cancer patients.
Oncology (Williston Park); 1990 May; 4(5):76. PubMed ID: 2143412
[No Abstract] [Full Text] [Related]
30. [Drug resistance in malignant neoplasms].
Czownicki Z
Pol Tyg Lek; 1982 Apr; 37(6):173-5. PubMed ID: 7122313
[No Abstract] [Full Text] [Related]
31. [Pharmacokinetic mechanisms of resistance to anticancer medications].
Robert J
Bull Cancer; 1994 Dec; 81 Suppl 2():78s-81s. PubMed ID: 7727864
[TBL] [Abstract][Full Text] [Related]
32. Overcoming drug resistance in the treatment of cancer.
Am Pharm; 1984 Apr; NS24(4):12-4. PubMed ID: 6720567
[No Abstract] [Full Text] [Related]
33. Fluoropyrimidine resistance in colon cancer.
Gorlick R; Banerjee D
Expert Rev Anticancer Ther; 2002 Aug; 2(4):409-16. PubMed ID: 12647984
[TBL] [Abstract][Full Text] [Related]
34. [Research advance on role of tumor microenvironment in mediating acquired drug resistance].
Ma XL; Xing H; Ma D
Ai Zheng; 2007 Aug; 26(8):923-6. PubMed ID: 17697561
[TBL] [Abstract][Full Text] [Related]
35. Integrins and extracellular matrix: a novel mechanism of multidrug resistance.
Elliott T; Sethi T
Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988
[TBL] [Abstract][Full Text] [Related]
36. [Prevention of resistance to chemotherapy in the therapeutic strategy for cancer].
Droz JP
Bull Cancer; 1994 Dec; 81 Suppl 2():91s-94s. PubMed ID: 7727869
[No Abstract] [Full Text] [Related]
37. Evolution of chemotherapy with platinum compounds.
Walker EM; Walker SM
Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
[TBL] [Abstract][Full Text] [Related]
38. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
39. Multidrug resistance in cancer: its mechanism and its modulation.
Pauwels EK; Erba P; Mariani G; Gomes CM
Drug News Perspect; 2007; 20(6):371-7. PubMed ID: 17925891
[TBL] [Abstract][Full Text] [Related]
40. [Novel targets for cancer chemotherapy].
Inoue S
Gan To Kagaku Ryoho; 1996 Jan; 23(2):191-201. PubMed ID: 8611047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
